Citation Impact
Citing Papers
Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society
2016 Standout
Antibiotics and antiseptics for preventing infection in people receiving revision total hip and knee prostheses: a systematic review of randomized controlled trials
2016
Eating habits and lifestyle changes during COVID-19 lockdown: an Italian survey
2020 Standout
Risk factors of treatment failure in community acquired pneumonia: implications for disease outcome
2004
Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults
2007 Standout
The Epidemic of Antibiotic-Resistant Infections: A Call to Action for the Medical Community from the Infectious Diseases Society of America
2007 Standout
The Quinolones: Past, Present, and Future
2005
A review of the antimicrobial activity of clavulanate
2003
Appropriate antibiotic use and why it is important: the challenges of bacterial resistance
2003
Vancomycin MIC creep in non-vancomycin-intermediate Staphylococcus aureus (VISA), vancomycin-susceptible clinical methicillin-resistant S. aureus (MRSA) blood isolates from 2001 05
2007
Timing of Antibiotic Prophylaxis for Primary Total Knee Arthroplasty Performed during Ischemia
2008
Use of Monte Carlo Simulation to Design an Optimized Pharmacodynamic Dosing Strategy for Meropenem
2003
Monotherapy May Be Suboptimal for Severe Bacteremic Pneumococcal Pneumonia
2001
Sex Differences in Pharmacokinetics and Pharmacodynamics
2009
The quinolones: decades of development and use
2003
Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions
2014 Standout
BTS guidelines for the management of pleural infection in children
2005 Standout
Penetration of Anti-Infective Agents into Pulmonary Epithelial Lining Fluid
2011
Sex bias in neuroscience and biomedical research
2010 Standout
Community-acquired pneumonia
2003
Waves of resistance: Staphylococcus aureus in the antibiotic era
2009 Standout
What is a resistance gene? Ranking risk in resistomes
2014 Standout
The Etiology of Community‐Acquired Pneumonia in Australia: Why Penicillin plus Doxycycline or a Macrolide Is the Most Appropriate Therapy
2008
Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America
2008 Standout
Predicting Antimicrobial Resistance in Invasive Pneumococcal Infections
2005
Emergence of Levofloxacin-Resistant Pneumococci in Immunocompromised Adults after Therapy for Community-Acquired Pneumonia
2003
Resistance to Antibiotics: Are We in the Post-Antibiotic Era?
2005 Standout
Antibacterial drug resistance: implications for the treatment of patients with community-acquired pneumonia
2004
Fluoroquinolones: Action and Resistance
2003
Gender-Based Differences in Drug Prescription: Relation to Adverse Drug Reactions
2009
Infections associated with orthopedic implants
2006
Vaccination greatly reduces disease, disability, death and inequity worldwide
2008 Standout
A cytoprotective perspective on longevity regulation
2013 StandoutNobel
Implant infections: adhesion, biofilm formation and immune evasion
2018 Standout
Targeting DNA topoisomerase II in cancer chemotherapy
2009 Standout
DNA Topoisomerases and Their Poisoning by Anticancer and Antibacterial Drugs
2010 Standout
Streptococcus pneumoniae and community-acquired pneumonia: A cause for concern
2004
Levofloxacin
2003
Moxifloxacin
2004
Mechanism of Quinolone Action and Resistance
2014 Standout
Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America
2019 Standout
Guidelines for the Treatment of Hypothyroidism: Prepared by the American Thyroid Association Task Force on Thyroid Hormone Replacement
2014 Standout
Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management
2015 Standout
Acinetobacter baumannii : Emergence of a Successful Pathogen
2008 Standout
Clinical practice guidelines for antimicrobial prophylaxis in surgery
2013 Standout
Antimicrobial Treatment Guidelines for Acute Bacterial Rhinosinusitis
2004
Antibiotics and Bacterial Resistance in the 21st Century
2014 Standout
Effect of phosphate binders upon TSH and l-thyroxine dose in patients on thyroid replacement
2007
A Review of Antibiotic Use in Food Animals: Perspective, Policy, and Potential
2012 Standout
Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children
2011 Standout
Bacterial Resistance to β-Lactam Antibiotics: Compelling Opportunism, Compelling Opportunity
2005 Standout
Fluorine in Pharmaceuticals: Looking Beyond Intuition
2007 StandoutScience
Three Decades of β-Lactamase Inhibitors
2010 Standout
Interaction of obesity and infections
2015
Clinical Practice Guideline (Update): Adult Sinusitis
2015 Standout
An Epidemiological Investigation of a Sustained High Rate of Pediatric Parapneumonic Empyema: Risk Factors and Microbiological Associations
2002
Clinical practice guideline: Adult sinusitis
2007 Standout
Pharmacodynamic Profiling of Piperacillin in the Presence of Tazobactam in Patients through the Use of Population Pharmacokinetic Models and Monte Carlo Simulation
2004
Prescribed drugs containing nitrogen heterocycles: an overview
2020 Standout
In Vitro Antibacterial Activities of JNJ-Q2, a New Broad-Spectrum Fluoroquinolone
2010
Works of Michael Kays being referenced
Azithromycin treatment failure in community-acquired pneumonia caused by Streptococcus pneumoniae resistant to macrolides by a 23S rRNA mutation
2002
Comparison of Five β‐Lactam Antibiotics Against Common Nosocomial Pathogens Using the Time Above MIC at Different Creatinine Clearances
1999
Effects of sevelamer hydrochloride and calcium acetate on the oral bioavailability of ciprofloxacin
2003
Steady-state pharmacokinetics and pharmacodynamics of piperacillin and tazobactam administered by prolonged infusion in obese patients
2012
Sex‐Related Differences in the Pharmacokinetics of Oral Ciprofloxacin
2004
Levofloxacin Treatment Failure in a Patient with Fluoroquinolone‐Resistant Streptococcus pneumoniae Pneumonia
2002
Fluoroquinolone susceptibility, resistance, and pharmacodynamics versus clinical isolates of Streptococcus pneumoniae from Indiana
2001
Comparative In Vitro Activity and Pharmacodynamics of Five Fluoroquinolones Against Clinical Isolates of Streptococcus pneumoniae
2000
Selection of a gyrA Mutation and Treatment Failure with Gatifloxacin in a Patient with Streptococcus pneumoniae with a Preexisting parC Mutation
2007
In Vitro Activity and Pharmacodynamics of Oral β‐Lactam Antibiotics Against Streptococcus pneumoniae from Southeast Missouri
1999
Levofloxacin pharmacokinetics in ESRD and removal by the cellulose acetate high performance-210 hemodialyzer
2003
Impact of different statistical methodologies on the evaluation of the in-vitro MICs for Bacteroides fragilis of selected cephalosporins and cephamycins
1993
Antibiotic Prophylaxis and Tourniquet Inflation in Total Knee Arthroplasty
1990
In vitro activity and pharmacodynamics of azithromycin and clarithromycin against Streptococcus pneumoniae based on serum and intrapulmonary pharmacokinetics
2001
Comparative Pharmacokinetics and Pharmacodynamics of Doripenem and Meropenem in Obese Patients
2013